Clinical features of hypertrophic cardiomyopathy caused by mutation of a 'hot spot' in the alpha-tropomyosin gene

Journal of the American College of Cardiology

Volumn 29, Issue 3, 1997, Pages 635-640

  Coviello, Domenico A ^a,b   Maron, Barry J ^c   Spirito, Paolo ^d   Watkins, Hugh ^e,f   Vosberg, Hans Peter ^g   Thierfelder, Ludwig ^e,f,h   Schoen, Frederick J ^e   Seidman, J G ^a   Seidman, Christine E ^e,f,i  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b UNIVERSITY OF GENOA   (Italy)

^c MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^h MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

ⁱ HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TROPOMYOSIN;

ADULT; AGED; ARTICLE; CARDIOMYOPATHY; CLINICAL ARTICLE; ELECTROCARDIOGRAM; FEMALE; GENE MUTATION; GENOTYPE; HAPLOTYPE; HEART HYPERTROPHY; HISTOPATHOLOGY; HUMAN; MALE; PHENOTYPE; PRIORITY JOURNAL; SURVIVAL;

EID: 0031042881     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(96)00538-4     Document Type: Article

References (20)

1. Thierfelder L, Watkins H, MacRae C, et al. α-Tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 1994;77:701-12.
2. Watkins H, Conner D, Thierfelder L, et al. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nature Genet 1995;11:434-7.
3. Bonne G, Carrier L, Bercovici J, et al. Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nature Genet 1995;11:438-40.
4. Geisterfer-Lowrence AAT, Kass S, Tanigawa G, et al. A molecular basis for familial hypertrophie cardiomyopathy: a β cardiac myosin heavy chain gene missense mutation. Cell 1990;62:999-1006.
5. Watkins H, Rosenzweig A, Hwang DS, et al. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophie cardiomyopathy. N Engl J Med 1992;326:1108-14.
6. Poetter K, Jiang H, Hassanzadeh S, et al. Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nature Genet 1996;13:63-9.
7. Watkins H, McKenna WJ, Thierfelder L, et al. Mutations in the genes for cardiac troponin T and a tropomyosin mutations in hypertrophic cardiomyopathy. N Engl J Med 1995;332:1058-64.
8. Solomon SD, Wolff S, Watkins H, et al. Left ventricular hypertrophy and morphology in familial hypertrophic cardiomyopathy associated with mutations of the beta-myosin heavy chain gene. J Am Coll Cardiol 1993;22:498-505.
9. Nakajima-Taniguchi C, Matsui H, Nagata S, Kishimoto T, Yamauchi-Takihara K. Novel missense mutation in α-tropomyosin gene found in Japanese patients with hypertrophic cardiomyopathy. J Mol Cell Cardiol 1995;27:2053-8.
10. Watkins H, Anan R, Coviello DA, Spirito P, Seidman JG, Seidman CE. A de novo mutation in α-tropomyosin that causes hypertrophic cardiomyopathy. Circulation 1995;91:2302-5.
11. Klues HG, Sniffers A, Maron BJ. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol 1995;26:1699-1708.
12. MacRae C, Ghaisas N, Kass S, et al. Familial hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3. J Clin Invest 1995;96:1216-20.
13. Thierfelder L, MacRae C, Watkins H, et al. A familial hypertrophic cardiomyopathy locus maps to chromosome 15q2. Proc Natl Acad Sci USA 1993;90:6270-4.
14. Schofield DE. Determination of chromosomal aneuploidy using paraffin-embedded tissue. In: Dracopoli NC, Haines JL, Korf BR, et al., editors. Current Protocols in Human Genetics. New York: Wiley & Sons, 1994:8.8.1-8.8.9.
15. Anan R, Greve G, Thierfelder L, et al. Prognostic implications of novel β-cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy. J Clin Invest 1994;93:280-5.
16. Cooper DN, Youssoufian H. The CpG dinucleotide and human genetic disease. Hum Genet 1988;78:151-5.
17. Ruiz-Opazo N, Nadal-Ginard B. Alpha-tropomyosin gene organization: alternative splicing of duplicated isotype-specific exons accounts for the production of smooth and striated muscle isoforms. J Biol Chem 1987;262: 4755-65.
18. Hollman A, Goodwin JF, Teare D, Renwick JW. A family with obstructive cardiomyopathy (asymmetrical hypertrophy). Br Heart J 1960;22:449-56.
19. Watkins H, Seidman JG, Seidman CE. Familial hypertrophic cardiomyopathy: a genetic model of cardiac hypertrophy. Hum Mol Genet 1995;4:1721-7.
20. Roberts R. Molecular genetics. Therapy or terror? Circulation 1994;89:499-500.